Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
Clinical trial NCT06095141 · RECRUITING
Trial details
- NCT number
- NCT06095141
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2025-10-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.